Effectiveness of tailored pain management in patients with chronic back pai

Completed

• Conditions: Chronic back pain; Musculoskeletal Diseases; Dorsalgia

• Registration Number: ISRCTN25592008
• Lead Sponsor: Zurzach Rehabilitation Foundation SPA (Switzerland)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-06-17
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1. Stationary patients of RehaClinic of at least 18 years old, either sex
2. Diagnosis of chronic back pain: at least 3 months of continuous back pain localised in the lumbar, thoracic, and/or cervical region
3. Willingness to learn behavioural patterns and motivation to participate in graded activity exercise programs
4. Ability to formulate realistic functional goals
5. Sufficient cognitive abilities and German language skills to understand the content of the interventions
6. Agreement to participate in the program and the assessment by written, signed informed consent

Exclusion Criteria

1. Severe somatic illness requiring specific treatment such as cancer, inflammatory rheumatic disease, neurological disease, pain after a recent operation (less than 6 months)
2. Specific back pain, defined as herniated disc, ankylosing spondylitis, spondylolisthesis, spinal fracture, or other relevant neurological diseases
3. Specific medical disorders and cardiovascular diseases, preventing participation at physical exercise
4. Pregnancy
5. Manifest psychiatric disorder such as dementia, psychosis, suicidality
6. Whiplash associated disorders

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Self-reported functional disability (Oswestry Disability Index), measured at T0, T2, T3 and T6.<br><br>Timepoints: <br>T0: 4 weeks before entry<br>T1: entry to pain programme<br>T2: discharge from pain programme<br>T3: 3 months follow-up<br>T6: one year follow-up

Secondary Outcome Measures

Name	Time	Method
1. Observed functional disability: the physical performance tests Back Performance Scale (BPS) and 5-Minute Walk Distance, measured at T1 and T2<br>2. Global perceived effect on daily functioning, measured at T2, T3 and T6<br>3. The Numeric Rating Scale (NRS) for pain, measured at T1, T2, T3 and T6<br>4. The subscales Ability to decrease pain, and Ability to control pain of the Coping Strategies Questionnaire (CSQ), measured at T1, T2, T3 and T6<br>5. Mental health (Hospital Anxiety and Depression Scale [HADS]), measured at T1, T2, T3 and T6<br>6. Pain Catastrophising Scale (PCS), measured at T1, T2, T3 and T6<br>7. Treatment expectancy and credibility (Credibility/Expectancy Questionnaire [CEQ]), measured at T1<br><br>Timepoints: <br>T0: 4 weeks before entry<br>T1: entry to pain programme<br>T2: discharge from pain programme<br>T3: 3 months follow-up<br>T6: one year follow-up